Detalhe da pesquisa
1.
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.
Prostate
; 84(9): 888-892, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561317
2.
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Cancer
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564301
3.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Oncologist
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630540
4.
Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.
Prostate
; 83(16): 1602-1609, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644774
5.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382533
6.
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma.
Oncologist
; 28(12): 1079-1084, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432304
7.
Cardiovascular Toxicities Associated with Tyrosine Kinase Inhibitors.
Curr Cardiol Rep
; 25(4): 269-280, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795308
8.
Women's sexual function before and during COVID-19 pandemic: A systematic review and meta-analysis.
J Obstet Gynaecol Res
; 48(9): 2285-2295, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844087
9.
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
Oncologist
; 26(12): 1006-e2129, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423501
10.
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
Oncologist
; 26(9): 751-760, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157173
11.
12.
Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors.
Urol Pract
; 11(1): 32-35, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903742
13.
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy.
Eur Urol Oncol
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735779
14.
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.
JAMA Netw Open
; 7(5): e249417, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696168
15.
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations.
Eur Urol Focus
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38580524
16.
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.
JCO Precis Oncol
; 8: e2300574, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38781543
17.
Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.
Hum Pathol
; 144: 28-33, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278448
18.
Advances in the treatment of metastatic prostate cancer.
Trends Cancer
; 9(10): 840-854, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442702
19.
An Update on the Treatment of Papillary Renal Cell Carcinoma.
Cancers (Basel)
; 15(3)2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765524
20.
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer.
Eur J Cancer
; 192: 113249, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672815